| 04-10-2012 04:24 PM CET - Health & Medicine |
|
Lower costs of conducting trials in India is driving the clinical trials market
Press release from: Netscribes India
Netscribes (India) Pvt. Ltd., launches Clinical Trials Market in India 2012 report covering a market which has a strong foothold in India. It is a part of Netscribes’ Healthcare Industry Series reports.
Mumbai, India – April 10, 2012 – Netscribes (India) Pvt. Ltd., a knowledge consulting solutions company, announces the launch of its report Clinical Trials Market in India 2012. The Indian market for clinical trials has great potential. Due to the rapidly growing need for developing newer drugs, and the increasing spend on R&D by pharmaceutical companies; the market is exhibiting significant growth. This is providing contract research organizations the opportunity to expand their operations and earn higher incomes.
The report provides a snapshot of the clinical trials market. It begins with an introduction section which briefly discusses the various stages in clinical trials. This section also discusses the various services provided by contract research organizations. This is followed by the market overview section which provides an insight into the market and highlights the market size and growth of clinical trials in the country. India’s current and projected share in the global clinical trials market has also been provided. The section also analyses the number of new trials registered in the country each year and segmentation of trials on the basis of the therapeutic area. The distribution of trials currently under progress, on the basis of the phase in which they are in, is also provided. Moreover the segmentation of trials on the basis of the sponsors has also been included in this section. The major pharmaceutical companies that are sponsoring trials in India have also been mentioned.
This is followed by an analysis of the drivers leading to growth in the market. This includes cost competitiveness, vast patient population with diverse number of diseases, increasing R&D expenditure by pharmaceutical companies, friendly regulatory environment, sound medical infrastructure and international quality standards. The main challenges to the market include shortage of research professionals, delays in trial approval, lack of data exclusivity and challenges of unethical trials. A section on government regulations in the industry has also been included. It covers the various government regulations outlining the legal and regulatory framework for conducting clinical trials in India.
The competition section provides an overview of the competitive landscape in the industry and includes a detailed profile of the major players in the market. The Porter’s Five Forces analysis for the clinical trials market is provided in this section. A summary of the major players operating in the market has also been provided in the form of a bubble chart. It also includes the list of products and services, key people, financial snapshot, key ratios and key recent developments for the major players.
A brief profile of the major clinical research institutes in the country and the key recent developments that have taken place in the market have been provided in the subsequent sections. A section providing strategic recommendations has been added at the end of the report which gives effective solutions to existing and potential players for improving market share and increasing their profitability.
About Netscribes (India) Pvt. Ltd.
Netscribes (www.netscribes.com) is a pioneering knowledge consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment & business research, business & corporate intelligence, publishing services and customized knowledge database creation. At its core lies a true value proposition that draws upon a vast knowledge base.
Netscribes India Pvt. Ltd.
3rd floor, Saberwal House
55B Mirza Ghalib Street
Kolkata - 700 016
West Bengal, India
Tel: +91 33 4064 6215
sales@netscribes.com
This release was published on openPR.
Mumbai, India – April 10, 2012 – Netscribes (India) Pvt. Ltd., a knowledge consulting solutions company, announces the launch of its report Clinical Trials Market in India 2012. The Indian market for clinical trials has great potential. Due to the rapidly growing need for developing newer drugs, and the increasing spend on R&D by pharmaceutical companies; the market is exhibiting significant growth. This is providing contract research organizations the opportunity to expand their operations and earn higher incomes.
The report provides a snapshot of the clinical trials market. It begins with an introduction section which briefly discusses the various stages in clinical trials. This section also discusses the various services provided by contract research organizations. This is followed by the market overview section which provides an insight into the market and highlights the market size and growth of clinical trials in the country. India’s current and projected share in the global clinical trials market has also been provided. The section also analyses the number of new trials registered in the country each year and segmentation of trials on the basis of the therapeutic area. The distribution of trials currently under progress, on the basis of the phase in which they are in, is also provided. Moreover the segmentation of trials on the basis of the sponsors has also been included in this section. The major pharmaceutical companies that are sponsoring trials in India have also been mentioned.
This is followed by an analysis of the drivers leading to growth in the market. This includes cost competitiveness, vast patient population with diverse number of diseases, increasing R&D expenditure by pharmaceutical companies, friendly regulatory environment, sound medical infrastructure and international quality standards. The main challenges to the market include shortage of research professionals, delays in trial approval, lack of data exclusivity and challenges of unethical trials. A section on government regulations in the industry has also been included. It covers the various government regulations outlining the legal and regulatory framework for conducting clinical trials in India.
The competition section provides an overview of the competitive landscape in the industry and includes a detailed profile of the major players in the market. The Porter’s Five Forces analysis for the clinical trials market is provided in this section. A summary of the major players operating in the market has also been provided in the form of a bubble chart. It also includes the list of products and services, key people, financial snapshot, key ratios and key recent developments for the major players.
A brief profile of the major clinical research institutes in the country and the key recent developments that have taken place in the market have been provided in the subsequent sections. A section providing strategic recommendations has been added at the end of the report which gives effective solutions to existing and potential players for improving market share and increasing their profitability.
About Netscribes (India) Pvt. Ltd.
Netscribes (www.netscribes.com) is a pioneering knowledge consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment & business research, business & corporate intelligence, publishing services and customized knowledge database creation. At its core lies a true value proposition that draws upon a vast knowledge base.
Netscribes India Pvt. Ltd.
3rd floor, Saberwal House
55B Mirza Ghalib Street
Kolkata - 700 016
West Bengal, India
Tel: +91 33 4064 6215
sales@netscribes.com
This release was published on openPR.
News-ID: 217343
More releases
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.
Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.
© openPR 2012 | Imprint
More Releases from
Netscribes India
Comments about openPR
OpenPR is clearly structured and remains true to its principle of confining itself to the essential parts.
OpenPR has proven to be a very good and reliable partner to our media agency:
Within the shortest time the releases are online and go down well with the media representatives.
The success of OpenPR is reflected in the steadily increasing number of press releases.
It is good that OpenPR exists!
Ursula Koslik,Director Marketing & PR, F+W Hamburg
OpenPR has proven to be a very good and reliable partner to our media agency:
Within the shortest time the releases are online and go down well with the media representatives.
The success of OpenPR is reflected in the steadily increasing number of press releases.
It is good that OpenPR exists!
Ursula Koslik,Director Marketing & PR, F+W Hamburg

